Hu Lixia, Kong Fanliang, Pan Yueyin
Department of Oncology, The Second People's Hospital of Hefei, Hefei, Anhui, China.
Department of Oncology, Anhui Province Hospital, Hefei, Anhui, China.
Onco Targets Ther. 2018 Feb 5;11:703-710. doi: 10.2147/OTT.S151129. eCollection 2018.
Previous studies investigating the association between interleukin-17A (IL-17A) G197A polymorphism and gastric cancer risk have provided inconsistent results. We, therefore, conducted this meta-analysis to clarify the association between IL-17A G197A polymorphism and gastric cancer risk.
We searched PubMed, Excerpta Medica Database, and CNKI databases to identify relevant studies up to June 10, 2017. A total of 16 case-control studies including 6,624 cases and 7,631 controls were identified.
Overall, significant associations between IL-17A G197A polymorphism and gastric cancer risk were observed (A vs G: OR =1.24, 95% CI =1.14-1.36; AA vs GG: OR =1.63, 95% CI =1.35-1.96; GA vs GG: OR =1.12, 95% CI =1.01-1.25; AA+GA vs GG: OR =1.23, 95% CI =1.11-1.35; AA vs GA+GG: OR =1.54, 95% CI =1.27-1.87). Similar associations were also observed in Asian population (A vs G: OR =1.25, 95% CI =1.15-1.37; AA vs GG: OR =1.62, 95% CI =1.33-1.97; GA vs GG: OR =1.16, 95% CI =1.07-1.25; AA+GA vs GG: OR =1.24, 95% CI =1.15-1.33; AA vs GA+GG: OR =1.51, 95% CI =1.23-1.85), in Caucasian population (AA vs GA+GG: OR =2.19, 95% CI =1.40-3.44), and in the hospital-based controls' subgroup (A vs G: OR =1.30, 95% CI =1.17-1.45; AA vs GG: OR =1.81, 95% CI =1.46-2.25; AA+GA vs GG: OR =1.27, 95% CI =1.12-1.43; AA vs GA+GG: OR =1.71, 95% CI =1.34-2.18).
The current meta-analysis suggests that IL-17A G197A polymorphism might enhance gastric cancer risk.
既往研究探讨白细胞介素 - 17A(IL - 17A)基因G197A多态性与胃癌风险之间的关联,结果并不一致。因此,我们进行了这项荟萃分析,以阐明IL - 17A基因G197A多态性与胃癌风险之间的关联。
我们检索了PubMed、医学文摘数据库和中国知网数据库,以识别截至2017年6月10日的相关研究。共纳入16项病例对照研究,包括6624例病例和7631例对照。
总体而言,观察到IL - 17A基因G197A多态性与胃癌风险之间存在显著关联(A与G比较:比值比[OR]=1.24,95%可信区间[CI]=1.14 - 1.36;AA与GG比较:OR =1.63,95%CI =1.35 - 1.96;GA与GG比较:OR =1.12,95%CI =1.01 - 1.25;AA + GA与GG比较:OR =1.23,95%CI =1.11 - 1.35;AA与GA + GG比较:OR =1.54,95%CI =1.27 - 1.87)。在亚洲人群(A与G比较:OR =1.25,95%CI =1.15 - 1.37;AA与GG比较:OR =1.62,95%CI =1.33 - 1.97;GA与GG比较:OR =1.16,95%CI =1.07 - 1.25;AA + GA与GG比较:OR =1.24,95%CI =1.15 - 1.33;AA与GA + GG比较:OR =1.51,95%CI =1.23 - 1.85)、高加索人群(AA与GA + GG比较:OR =2.19,95%CI =1.40 - 3.44)以及基于医院对照的亚组(A与G比较:OR =1.30,95%CI =1.17 - 1.45;AA与GG比较:OR =1.81,95%CI =1.46 - 2.25;AA + GA与GG比较:OR =1.27,95%CI =1.12 - 1.43;AA与GA + GG比较:OR =1.71,95%CI =1.34 -